| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2849060 | American Heart Journal | 2007 | 8 Pages |
Abstract
In a subgroup analysis, a reperfusion strategy including enoxaparin significantly improved outcomes compared with UFH among high-risk STEMI patients with DM undergoing fibrinolysis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
David A. MD, MPH, Elliott M. MD, Sabina A. MPH, Jie MS, Mikhail MD, Sema MD, Ashok Joseph MD, Andrzej MD, Eugene MD, from the TIMI Study Group from the TIMI Study Group,